miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MicroRNA‐375‐3p Enhances Chemosensitivity to 5‐Fluorouracil by Targeting Thymidylate Synthase in Colorectal Cancer

(2020) Fei Xu et al.   CANCER SCIENCE

Resveratrol Sensitizes Colorectal Cancer Cells to Cetuximab by Connexin 43 Upregulation-Induced Akt Inhibition

(2020) Yijia Wang et al.   Frontiers in Oncology

Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1

(2020) Xiaoping Pan et al.   Frontiers in Oncology

5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation

(2020) Yong-Hee Cho et al.   Nature Communications

The prognostic effect of adjuvant chemotherapy in the colon cancer patients with solitary lymph node metastasis

(2019) Seung-Seop Yeom et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

The emerging role of noncoding RNAs in colorectal cancer chemoresistance

(2019) Ling Wei et al.   CELLULAR ONCOLOGY

Strategies for Colorectal Cancer Screening

(2019) Uri Ladabaum et al.   GASTROENTEROLOGY

Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors

(2019) Jesús García-Foncillas et al.   Frontiers in Oncology

Wnt signaling and drug resistance in cancer

(2019) Zheng Zhong et al.   MOLECULAR PHARMACOLOGY

circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637

(2019) Yanli Zhang et al.   EBioMedicine

Overview of microRNA-199a Regulation in Cancer

(2019) Qiwen Wang et al.   Cancer Management and Research

Reduction of Membrane Protein CRIM1 Decreases E-Cadherin and Increases Claudin-1 and MMPs, Enhancing the Migration and Invasion of Renal Carcinoma Cells

(2018) Nobutaka Ogasawara et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway

(2018) Qiang Zhang et al.   CELL BIOCHEMISTRY AND FUNCTION

Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116

(2018) Egle Kukcinaviciute et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative Review

(2018) Giulia Fornasier et al.   ADVANCES IN THERAPY

Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p

(2018) Marzieh Ghanbarian et al.   BIOMEDICINE & PHARMACOTHERAPY

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation

(2018) Jacob O'Brien et al.   Frontiers in Endocrinology

Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling

(2017) Georg Emons et al.   MOLECULAR CANCER RESEARCH

lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling

(2017) Yuanyuan Lu et al.   NATURE MEDICINE

MicroRNA-146a induces immune suppression and drug-resistant colorectal cancer cells

(2017) Samaneh Khorrami et al.   TUMOR BIOLOGY

Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1+ colorectal cancer stem cells

(2017) Binghe Chen et al.   TUMOR BIOLOGY

The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-β-catenin signaling axis

(2017) Araceli Valverde et al.   Oncotarget

Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway

(2017) Dong Ren et al.   Oncotarget

RECIST 1.1—Update and clarification: From the RECIST committee

(2016) Lawrence H. Schwartz et al.   EUROPEAN JOURNAL OF CANCER

Inhibition of the proliferation and acceleration of migration of vascular endothelial cells by increased cysteine-rich motor neuron 1

(2015) Yukiko Nakashima et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1

(2015) Paula Mussnich et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

Predicting effective microRNA target sites in mammalian mRNAs

(2015) Vikram Agarwal et al.   eLife

Acquired resistance to EGFR-targeted therapies in colorectal cancer

(2014) Beth O. Van Emburgh et al.   Molecular Oncology

Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution

(2014) S. Misale et al.   Cancer Discovery

Increased TGF-  as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR-MET Interaction and Activation of MET Signaling in Colon Cancer Cells

(2013) T. Troiani et al.   CLINICAL CANCER RESEARCH

Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab

(2011) Toni M. Brand et al.   CANCER BIOLOGY & THERAPY

Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases

(2009) Bryan T. MacDonald et al.   DEVELOPMENTAL CELL

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer

(2009) Salvatore Siena et al.   JNCI-Journal of the National Cancer Institute

MicroRNAs in Cancer

(2008) Yong Sun Lee et al.   Annual Review of Pathology-Mechanisms of Disease

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

(2008) D L Wheeler et al.   ONCOGENE